肿瘤化疗多药耐药研究新进展

被引：7

作者：

徐志渊

李德锐

机构：

[1] 汕头大学医学院附属肿瘤医院

来源：

中国肿瘤 | 2006年 / 06期

关键词：

肿瘤; 多药耐药; 药物疗法;

D O I：

暂无

中图分类号：

R730.5 [肿瘤治疗学];

学科分类号：

摘要：

肿瘤化疗失败的主要原因是多药耐药(MDR)的产生。肿瘤多药耐药的机制十分广泛,其中以ATP结合盒式结构超家族成员研究较多。文章重点综述目前研究较多的多药耐药机制,并对肿瘤耐药逆转进展作简要介绍。

引用

页码：382 / 385

页数：4

共 5 条

[1]

Comparison of Chemotherapy Response with P-Glycoprotein, Multidrug Resistance-Related Protein-1, and Lung Resistance-Related Protein Expression in Untreated Small Cell Lung Cancer[J] . J.-J. Yeh,N.-Y. Hsu,W.-H. Hsu,C.-H. Tsai,C.-C. Lin,J.-A. Liang.Lung . 2005 (3)

[2] Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure [J].

Guo, BQ ;

Villeneuve, DJ ;

Hembruff, SL ;

Kirwan, AF ;

Blais, DE ;

Bonin, M ;

Parissenti, AM .

BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (01) :31-51

[3] Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28) [J].

Giri, U ;

Terry, NHA ;

Kala, SV ;

Lieberman, MW ;

Story, MD .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) :511-521

[4]

Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance[J] . Liwu Fu,Yongju Liang,Liwen Deng,Yan Ding,Liming Chen,Yanli Ye,Xiaoping Yang,Qichao Pan.Cancer Chemotherapy and Pharmacology . 2004 (4)

[5] Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer [J].

Chiou, JF ;

Liang, JA ;

Hsu, WH ;

Wang, JJ ;

Ho, ST ;

Kao, A .

LUNG, 2003, 181 (05) :267-273

← 1 →